Mammalian RNA-dependent deaminases and edited mRNAs

Current Opinion in Cell Biology

Volumn 9, Issue 3, 1997, Pages 343-349

  Maas, Stefan ^a   Melcher, Thorsten ^a   Seeburg, Peter H ^a  

^a MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; APOLIPOPROTEIN B; CALCIUM ION; CATION CHANNEL; DEAMINASE; DOUBLE STRANDED RNA; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MESSENGER RNA; NUCLEAR RNA;

ANIMAL CELL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA EDITING; SYNAPSE; TISSUE DISTRIBUTION; TRANSGENIC ANIMAL;

ANIMALIA; MAMMALIA;

EID: 0030900432     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80006-3     Document Type: Article

References (49)

1. Scott J: A place in the world for RNA editing. Cell 1995, 81:833-836. A very topical review on RNA editing. Includes intriguing thoughts on the evolution of different forms of RNA editing.
2. Benne R: RNA editing: how a message is changed. Curr Opin Genet Dev 1996, 6:221-231. A thorough review, particularly on recent progress in the area of apoB editing, and also on kinetoplastid editing.
3. Simpson L, Emeson R: RNA editing. Annu Rev Neurosci 1996, 19:27-52. A detailed review of different mechanisms of RNA editing.
4. Smith HC, Sowden MP: Base modification mRNA editing through deamination. The good, the bad and the unregulated. Trends Genet 1996, 12:418-424.
5. Bass BL: An I for editing. Curr Biol 1995, 5:598-600.
6. Seeburg PH: The role of RNA editing in controlling glutamate receptor channel properties. J Neurochem 1996, 66:1-5.
7. Brusa R, Zimmermann F, Koh D-S, Feldmeyer D, Gass P, Seeburg PH, Sprengel R: Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680. Shows, for the first time, the in vivo importance of editing the Q/R site in AMPA receptor subunit GluR-B pre-mRNA. Mice were constructed to carry one GluR-B allele that was incompetent for Q/R site editing and one wild-type allele. These mice developed a severe epileptic syndrome and died within three weeks of birth.
8. 2+ permeability of AMPA type receptors is not created by editing. The R/G site codon, however, is of the unedited version in Oreochromis and evidence for RNA editing at this site is presented.
9. Yamanaka S, Poksay KS, Balestra ME, Zeng G-Q, Innerarity TL: Cloning and mutagenesis of the rabbit apoB mRNA editing protein: a zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J Biol Chem 1994, 269:21725-21735.
10. Metha A, Banerjee S, Driscoll DM: Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro. J Biol Chem 1996, 45:28294-28299.
11. Schock D, Kuo S-R, Steinburg MF, Bolognino M, Sparks JD, Sparks CE, Smith HC: An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing. Proc Natl Acad Sci USA 1996, 93:1097-1102.
12. Yang Y, Smith HC: In vitro reconstitution of apolipoprotein B RNA editing activity from recombinant APOBEC-1 and McArdle cell extracts. Biochem Biophys Res Commun 1996, 218:797-801.
13. Yamanaka S, Poksay KS, Driscoll DM, Innerarity TL: Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem 1996, 271:11506-11510. This careful study investigates the influence of the mooring sequence on apoB RNA hyperediting as induced by APOBEC-1 overexpression in transgenic mice. The data are incorporated into a two-site model for the assembly of the editosome.
14. Skuse GR, Cappione AJ, Sowden M, Metheny LJ, Smith HC: The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res 1996, 24:478-486. This work describes a new potential substrate for APOBEC-1-catalyzed cytidine deamination.
15. Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, Taylor JM, Innerarity TL: Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA 1995, 92:8483-8487. This paper is particularly interesting with respect to the consequences of transgenic overexpression of APOBEC-1. The authors propose that hyperediting may lead to proto-oncogene activation.
16. •]).
17. Sowden M, Hamm JK, Spinelli S, Smith HC: Determinants involved in regulating the proportion of edited apolipoprotein B RNAs. RNA 1996, 2:274-288.
18. •].
19. Anant S, MacGinnitie AJ, Davidson NO: apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem 1995, 24:14762-14767.
20. •].
21. •].
22. •].
23. Farese RV Jr, Veniant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, Traber M, Ruland S, Stokowski RS, Huszar D, Young SG: Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci USA 1996, 93:6393-6398.
24. Chan L: Use of somatic gene transfer to study lipoprotein metabolism in experimental animals in vivo. Curr Opin Lipidol 1995,6:335-340.
25. Hughes SD, Rouy D, Navaratnam N, Scott J, Rubin EM: Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apoliprotein B editing in rabbits. Hum Gene Ther 1996, 7:39-49.
26. Teng B, Blumenthal S, Forte T, Navaratnam N, Scott J: Adenovirus-mediated gene transfer of rat apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem 1994, 269:29395-29404.
27. Sowden M, Hamm JK, Smith HC: Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J Biol Chem 1996, 271:3011-3017.
28. Herb A, Higuchi M, Sprengel R, Seeburg PH: Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. Proc Natl Acad Sci USA 1996, 93:1875-1880. This study localizes the intronic ECS for Q/R site editing in GluR5 and GluR6 pre-mRNA. This cis-acting element is approximately 2000 nucleotides 3′ of the exonic editing site. Although long-range interactions in RNA are common, the results of this study imply a large range of distances between exonic and intronic site and intronic ECS in RNAs edited by adenosine deamination.
29. •]).
30. Bass BL, Weintraub H: A developmentally regulated activity that unwinds RNA duplexes. Cell 1987, 48:607-613.
31. Kim U, Wang Y, Sanford T, Zeng Y, Nishikura K: Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci USA 1994, 91:11457-11461.
32. O'Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, Jenny A, Keller W: Cloning of cDNAs encoding mammalian double stranded RNA-specific adenosine deaminase. Mol Cell Biol 1995, 15:1389-1397.
33. Wang Y, Zeng Y, Murray JM, Nishikura K: Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. J Mol Biol 1995, 254:184-195.
34. Burd CG, Dreyfuss G: Conserved structures and diversity of functions of RNA-binding proteins. Science 1994, 265:615-621.
35. Herbert A, Lowenhaupt K, Spitzner J, Rich A: Chicken double-stranded RNA adenosine deaminase has apparent specificity for Z-DNA. Proc Natl Acad Sci USA 1995, 92:7550-7554.
36. Herbert A: RNA editing, introns and evolution. Trends Genet 1996, 12:6-9.
37. Lai F, Drakas R, Nishikura K: Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamate-gated ion channel transcripts. J Biol Chem 1996, 270:17098-17195. This careful study investigates RNA binding and catalytic domains of DRADA by mutagenic analysis. The results confirm the hypothesis of an evolutionary relationship between the hydrolytic deamination mechanism of DRADA and that of cytidine deaminases.
38. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M: A mammalian RNA editing enzyme. Nature 1996, 379:460-464. This paper characterizes RED1, the first homolog of DRADA. RED1 is shown to catalyze Q/R site and R/G site editing in GluR-B pre-mRNA in vitro.
39. Gerber A, O'Connell MA, Keller W: Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 1997, in press.
40. Lai F, Chen C-X, Carter KC, Nishikura K: Editing of GluR-B ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol Cell Biol 1997, in press.
41. Mittaz L, Scott HS, Rossier C, Seeburg PH, Higuchi M, Antonarakis SE: Cloning of a human RNA editing deaminase (hRED1) of glutamate receptors which maps to chromosome 21q22.3. Genomics 1997, in press.
42. Welcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M: RED2, a brain specific member of the RNA specific adenosine deaminase family. J Biol Chem 1996, 271:31795-31798.
43. Dabiri GA, Lai F, Drakas RA, Nishikura K: Editing of the GluR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase. EMBO J 1996, 15:34-45. The authors show that recombinantly expressed DRADA does not edit the Q/R site in GluR-B mRNA. The efficiency and site selectivity can be improved by adding nuclear extract from cultured cells.
44. Hurst SR, Hough RF, Aruscavage PJ, Bass BL: Deamination of mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deaminase: similarities to in vivo RNA editing. RNA 1995, 1:1051-1060.
45. Poison AG, Bass BL: Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J 1994, 13:5701-5711.
46. Polson AG, Bass BL, Casey JL: RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 1996, 380:454-456. This study investigates the activity of DRADA in editing the amber/W site in the hepatitis delta virus antigenome. The authors include a mutagenic analysis of the editing site to show that mutations have similar effects on editing in vitro and in vivo.
47. Burns CM, Chu H, Rueter SM, Sanders-Bush E, Emeson RB: Identification and characterization of RNA editing within the serotonin 2C receptor [abstract 385.9]. Soc Neurosci 1996. The authors show that RNA for a particular serotonin receptor subtype is edited in several positions by adenosine deamination.
48. Ma J, Yian R, Rausa III FM, Colley KJ: Two naturally occurring alpha 2,6-sialyltransferase forms with a single amino acid change in the catalytic domain differ in their catalytic acticity and proteolytic processing. J Biol Chem 1997, 272:672-679. This study identifies a hepatic transcript which undergoes RNA editing by adenosine deamination.
49. Petschek JP, Mermer MJ, Scheckelhoff MR, Simone AA, Vaughn JC: RNA editing in Drosophila 4f-mp gene nuclear transcripts by multiple A-to-G conversion. J Mol Biol 1996, 259:885-890.